Sino Biopharmaceutical Limited: all 470 studies
Page 5 of 5. Open to participants first (164), then studies with results posted, then the rest; newest registration first within each.
- Bioequivalence Study of Trifluridine and Tipiracil Tablets in Colorectal Cancer PatientsCompletedNCT03974594Phase 1
- Safety and Efficacy Study of TQ-B3101 in Patients With ROS1-positive Non-Small Cell Lung Cancer (NSCLC)Status unknownNCT03972189Phase 2
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（NSCLC）Status unknownNCT03910127Phase 1
- Study of TQB2450 Combined With Anlotinib in Patients With Advanced Solid TumorsStatus unknownNCT03897283Phase 1
- Empiric Therapy of Patients With Persistent Fever and Agranulocytosis Using CaspofunginCompletedNCT03857399Phase 2
- Study of TQB2450 in Patients With Recurrent or Metastatic Squamous Cell Cancer of the Head and Neck（R/M SCCHN）Status unknownNCT03855384Phase 3
- A Study of TQB2450 Injection and Anlotinib Hydrochloride Capsules to Treat Triple Negative Breast Cancer (TNBC)Status unknownNCT03855358Phase 1
- A Phase I Study of TQB3616 on Tolerance and PharmacokineticsCompletedNCT03850873Phase 1
- Bioequivalence Study of Entecavir Tablets and Baraclude® Under Fasting Condition in Chinese Healthy VolunteersCompletedNCT03847246Not applicable
- A Study on Safety and Efficacy of TQB2450 Injection Combined With Anlotinib Hydrochloride Capsule in Patients With Advanced Biliary Adenocarcinoma/Hepatocellular CarcinomaStatus unknownNCT03825705Phase 1/2
- A Phase II Study to Evaluate the Safety and Efficacy of TQB2450 Injection in Relapsed or Refractory Classical Hodgkin's LymphomaStatus unknownNCT03800706Phase 2
- Study of TQB2303 in Patients With CD20-Positive Diffuse Large B-cell Lymphoma (DLBCL)Status unknownNCT03777085Phase 3
- Bioequivalence Study of Empagliflozin Tablet in Healthy Participants.CompletedNCT03771781Not applicable
- A Phase I Study of TQ-B3456 on Tolerance and PharmacokineticsTerminatedNCT03754244Phase 1
- Pharmacokinetic and Tolerance Study of TQ-A3326 in Healthy Participants.Status unknownNCT03714568Phase 1
- Gemcitabine and Cisplatin With/Without Anlotinib in Advanced Nasopharyngeal CarcinomaStatus unknownNCT03601975Phase 3
- Study of Anlotinib in Patients With Primary Malignant Bone TumorsStatus unknownNCT03527888Phase 2
- A Study of TQ-B3525 on Tolerance and PharmacokineticsStatus unknownNCT03510767Phase 1
- Salmeterol Xinafoate and Fluticasone Propinate Powder for Inhalation for AsthmaStatus unknownNCT03461627Phase 3
- Tolerance and Pharmacokinetics of TQB2450Status unknownNCT03460457Phase 1
- A Study of Anlotinib in Patients With Gastroenteropancreatic Neuroendocrine Tumor G3Status unknownNCT03457844Phase 2
- Study of TQB2303 in Patients With Aggressive CD20 Positive Non-Hodgkin's LymphomaStatus unknownNCT03456466Phase 1/2
- Tolerance and Pharmacokinetics of TQ-B3233Status unknownNCT03453034Phase 1
- A New Drug Used for Advanced CancerStatus unknownNCT03447145Phase 1
- A Phase 1/2 Study of FS118 in Patients With Advanced MalignanciesTerminatedNCT03440437Phase 1/2
- Magnesium Isoglycyrrhizinate Followed by Diammonium Glycyrrhizinate and Combined With Entecavir in Chronic Hepatitis BStatus unknownNCT03349008Phase 4
- Generic Zoledronic Acid Versus Original Zoledronic Acid in Postmenopausal Osteoporotic WomenStatus unknownNCT03158246Phase 4
- Intensive Medicines Monitoring Project of Palonosetron Hydrochloride Capsules (Ruo Shan®)Status unknownNCT03148704
- A Phase I Study of TQ-B3139 on Tolerance and PharmacokineticsStatus unknownNCT03099330Phase 1
- Study of Anlotinib in Patients With Small Cell Lung Cancer (ALTER1202)CompletedNCT03059797Phase 2
- A Phase I Study of TQ-B3101 on Tolerance and PharmacokineticsStatus unknownNCT03019276Phase 1
- A Phase I Study of TQ-B3234 on Tolerance and PharmacokineticsStatus unknownNCT02996838Phase 1
- A Phase I Study of TQ-B3395 on Tolerance and PharmacokineticsTerminatedNCT02944864Phase 1
- Evaluate Efficacy and Safety of Recombinant Factor VIII （rFVIII）Treatment of Severe or Moderately Severe Hemophilia AStatus unknownNCT02930317Phase 3
- A Phase I Study of Anlotinib on Pharmacokinetics to Assess the Effect of High Fat Diet in Advanced Cancer PatientsCompletedNCT02825563Phase 1
- A Study of Anlotinib in Patients With Hepatocellular CarcinomaStatus unknownNCT02809534Phase 2
- A Study of AL2846 on Tolerance and PharmacokineticsStatus unknownNCT02779699Phase 1
- A Phase I Additional Study of Anlotinib on Tolerance and PharmacokineticsStatus unknownNCT02752516Phase 1
- Efficacy and Safety Study of Magnesium Isoglycyrrhizinate Injection in Subjects With Acute Drug-induced Liver InjuryCompletedNCT02734966Phase 2
- A Multicenter Randomized Double-blind Clinical Study Evaluated the Safety, Pharmacokinetic and Pharmacodynamic Characteristics of Roflumilast in COPD PatientsTerminatedNCT02671942Phase 2
- Study of Anlotinib in Patients With Esophageal Squamous Cell Carcinoma (ALTER1102)CompletedNCT02649361Phase 2
- Study to Investigate the Absorption, Metabolism and Excretion of [14C] Anlotinib in Patients With Advanced Cancer PatientsCompletedNCT02622932Phase 1
- Study of Anlotinib in Patients With Medullary Thyroid Carcinoma(ALTER01031)CompletedNCT02586350Phase 2/3
- Study of Anlotinib in Patients With Differentiated Thyroid Cancer(ALTER01032)Status unknownNCT02586337Phase 2/3
- Study of Methylnaltrexone in Opioid-Induced Constipation PatientsStatus unknownNCT02574819Phase 2/3
- A Study of Sinotecean on Tolerance and PharmacokineticsStatus unknownNCT02469883Phase 1
- Study of Anlotinib in Patients With Gastric Cancer(ALTER0503)Status unknownNCT02461407Phase 2/3
- Study of Anlotinib in Patients With Soft Tissue Sarcoma（STS）(ALTER0203)Status unknownNCT02449343Phase 2/3
- Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0303）CompletedNCT02388919Phase 2/3
- Study of Anlotinib in Patients With Metastatic Colorectal Cancer（mCRC）(ALTER0703)CompletedNCT02332499Phase 2/3
- Efficacy and Safety of Imatinib Mesylate as First-line Treatment for the Patients With Chronic Phase of Chronic Myeloid LeukemiaStatus unknownNCT02317159Phase 4
- Efficacy and Safety of Domestic Tenofovir Tablets in Chinese Patients With Chronic Hepatitis BStatus unknownNCT02287857Not applicable
- Efficacy and Safety of Foscarnet Sodium and Sodium Chloride Injection in Patients With Herpes ZosterCompletedNCT02151240Phase 4
- Efficacy and Safety of L-Pantoprazole Sodium Injection to Treat Upper Gastrointestinal Ulcer BleedingStatus unknownNCT02108756Not applicable
- Phase II Study of Anlotinib in Patients With Advanced Renal Cell Carcinoma That Have Failed Or Are Intolerant To TKIs TherapyStatus unknownNCT02072044Phase 2
- Phase II Study of Anlotinib Versus Sunitinib in Patients With Advanced Renal Cell Carcinoma（RCC）Status unknownNCT02072031Phase 2
- To Predict Efficacy by Detecting Circulating Endothelial Cell Subsets and Blood Perfusion Parameters Changes in Vivo Tumor in the Phase II/III Study of Anlotinib in Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT02029209Phase 2/3
- A Phase Ⅳ Study of Decitabine in Myelodysplastic SyndromeStatus unknownNCT02013102Phase 4
- Efficacy and Safety of Raltitrexed-based Transarterial Chemoembolisation(TACE)for Colorectal Cancer Liver MetastasesStatus unknownNCT01959061Phase 4
- Efficacy and Safety of Colistimethate Sodium Injection Vial to Treat Hospital-acquired Pneumonia in AdultsStatus unknownNCT01940731Phase 2
- A Phase III Study of Faropenem in the Treatment of Adult Community-acquired Bacterial PneumoniaStatus unknownNCT01937832Phase 3
- Efficacy and Safety of Entecavir Maleate Tablets in Chinese Patients With Hepatitis BCompletedNCT01926288Phase 4
- Phase II Study of Anlotinib in Patients With Advanced Non-small Cell Lung Cancer（ALTER0302）CompletedNCT01924195Phase 2
- A Phase II Study of Faropenem in the Treatment of Adult Community-acquired Bacterial PneumoniaCompletedNCT01886053Phase 2
- A Phase II Study of Anlotinib in STS PatientsCompletedNCT01878448Phase 2
- A Phase II Study of Anlotinib in MTC PatientsCompletedNCT01874873Phase 2
- A Bioequivalence Study of Capecitabine TabletsCompletedNCT01846650Phase 1
- A Phase I Study of Anlotinib on Tolerance and PharmacokineticsCompletedNCT01833923Phase 1
- A Phase I Study of Subutinib Maleate Capsules on Toleration and PharmacokineticsStatus unknownNCT01806376Phase 1
- Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver InjuryStatus unknownNCT01802996Phase 4